Ultragenyx Pharmaceutical Inc at Piper Sandler Healthcare Conference Transcript
Okay. I think we're going to go ahead and get started. Thanks, everybody, for being here. My name is Chris Raymond. I'm one of the senior biotech analysts at Piper Sandler.
Pleased to introduce our next presenter, which is Ultragenyx. Emil Kakkis is with us, the President and CEO. We've got about 25 or so minutes for an informal Q&A just to go over sort of the format. I'd like to keep this as informal as possible. So if anybody in the audience has any questions, just raise your hand. Let me know, I'll make sure your question gets asked and answered.
Before we dive into Q&A, Emil, for the folks who might not be completely versed on the Ultragenyx story, maybe just walk us through the elevator pitch, if you will, and then I'll dive into my questions.
Sure, Chris. Happy be here with you again. Ultragenyx is now 13 years in from founding. And in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
